BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 36934987)

  • 1. Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results.
    Kumar HU; Nearing BD; Mittal S; Premchand RK; Libbus I; DiCarlo LA; Amurthur B; KenKnight BH; Anand IS; Verrier RL
    Int J Cardiol; 2023 Jun; 381():37-44. PubMed ID: 36934987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study.
    DiCarlo LA; Libbus I; Kumar HU; Mittal S; Premchand RK; Amurthur B; KenKnight BH; Ardell JL; Anand IS
    ESC Heart Fail; 2018 Feb; 5(1):95-100. PubMed ID: 29283224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Dixit S; Libbus I; DiCarlo LA; Ardell JL; Rector TS; Amurthur B; KenKnight BH; Anand IS
    J Card Fail; 2014 Nov; 20(11):808-16. PubMed ID: 25187002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic regulation therapy suppresses quantitative T-wave alternans and improves baroreflex sensitivity in patients with heart failure enrolled in the ANTHEM-HF study.
    Libbus I; Nearing BD; Amurthur B; KenKnight BH; Verrier RL
    Heart Rhythm; 2016 Mar; 13(3):721-8. PubMed ID: 26601770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF.
    Anand IS; Konstam MA; Klein HU; Mann DL; Ardell JL; Gregory DD; Massaro JM; Libbus I; DiCarlo LA; Udelson JJE; Butler J; Parker JD; Teerlink JR
    ESC Heart Fail; 2020 Feb; 7(1):75-83. PubMed ID: 31984682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vagus Nerve Stimulation Provides Multiyear Improvements in Autonomic Function and Cardiac Electrical Stability in the ANTHEM-HF Study.
    Nearing BD; Anand IS; Libbus I; Dicarlo LA; Kenknight BH; Verrier RL
    J Card Fail; 2021 Feb; 27(2):208-216. PubMed ID: 33049374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended Follow-Up of Patients With Heart Failure Receiving Autonomic Regulation Therapy in the ANTHEM-HF Study.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Dixit S; Libbus I; DiCarlo LA; Ardell JL; Rector TS; Amurthur B; KenKnight BH; Anand IS
    J Card Fail; 2016 Aug; 22(8):639-42. PubMed ID: 26576716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Follow-Up of Patients with Heart Failure and Reduced Ejection Fraction Receiving Autonomic Regulation Therapy in the ANTHEM-HF Pilot Study.
    Sharma K; Premchand RK; Mittal S; Monteiro R; Libbus I; DiCarlo LA; Ardell JL; Amurthur B; KenKnight BH; Anand IS
    Int J Cardiol; 2021 Jan; 323():175-178. PubMed ID: 33038408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction.
    Chen C; Cheng K; Gao X; Zou T; Pang Y; Ling Y; Xu Y; Xu Y; Chen Q; Zhu W; Ge J
    ESC Heart Fail; 2023 Feb; 10(1):518-531. PubMed ID: 36325978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility Studies.
    Udelson JE; Barker CM; Wilkins G; Wilkins B; Gooley R; Lockwood S; Potter BJ; Meduri CU; Fail PS; Solet DJ; Feldt K; Kriegel JM; Shaburishvili T
    JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1121-1130. PubMed ID: 37115132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Autonomic Engagement Assessed by Heart Rate Dynamics During Vagus Nerve Stimulation in Patients With Heart Failure in the ANTHEM-HF Trial.
    Nearing BD; Libbus I; Amurthur B; Kenknight BH; Verrier RL
    J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1072-7. PubMed ID: 27221316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.
    Solomon SD; Ostrominski JW; Vaduganathan M; Claggett B; Jhund PS; Desai AS; Lam CSP; Pitt B; Senni M; Shah SJ; Voors AA; Zannad F; Abidin IZ; Alcocer-Gamba MA; Atherton JJ; Bauersachs J; Ma CS; Chiang CE; Chioncel O; Chopra V; Comin-Colet J; Filippatos G; Fonseca C; Gajos G; Goland S; Goncalvesová E; Kang SM; Katova T; Kosiborod MN; Latkovskis G; Lee AP; Linssen GCM; Llamas-Esperón G; Mareev V; Martinez FA; Melenovský V; Merkely B; Nodari S; Petrie MC; Saldarriaga CI; Saraiva JFK; Sato N; Schou M; Sharma K; Troughton R; Udell JA; Ukkonen H; Vardeny O; Verma S; von Lewinski D; Voronkov LG; Yilmaz MB; Zieroth S; Lay-Flurrie J; van Gameren I; Amarante F; Viswanathan P; McMurray JJV
    Eur J Heart Fail; 2024 Jun; 26(6):1334-1346. PubMed ID: 38733212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
    Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
    Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.